Journal of Allergy and Clinical Immunology 1996-11-01

Chloride transport and the actions of nedocromil sodium and cromolyn sodium in asthma.

E W Alton, A A Norris

Index: J. Allergy Clin. Immunol. 98(5 Pt 2) , S102-5; discussion S105-6, (1996)

Full Text: HTML

Abstract

Nedocromil sodium has been shown to be capable of inhibiting chloride ion flux in mast cells, epithelial cells, and neurons. This feature may explain how it can prevent responses such as mast-cell degranulation, the effects of osmolarity changes in the airways, and neuronal activation. This mechanism may also provide a unifying hypothesis to explain the effects of nedocromil sodium on a range of cell types involved in asthma, such as sensory and efferent neurons and cells involved in inflammation.

Related Compounds

  • Nedocromil

Related Articles:

Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling.

2015-02-01

[Hypertension 65(2) , 328-34, (2015)]

Diagnostic accuracy of the bronchodilator response in children.

2013-09-01

[J. Allergy Clin. Immunol. 132(3) , 554-559.e5, (2013)]

This asthma treatment has a lasting side effect in children.

2013-09-01

[J. Fam. Pract. 62(9) , 500-2, (2013)]

Corticosteroid use and bone mineral accretion in children with asthma: Effect modification by vitamin D

2012-07-01

[J. Allergy Clin. Immunol. 130(1) , 53-60.e4, (2012)]

Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1.

2009-06-15

[Biochem. Pharmacol. 77(12) , 1814-26, (2009)]

More Articles...